Approaches to Process Development

The cost and pace of developing active compounds for the pharmaceutical and agricultural industries is dramatically increasing. Efficient development of processes to prepare kilogram quantities of drug candidates and active ingredients is necessary to sustain the pace of drug development and recoup the expenses of development. Devising and implementing a reliable manufacturing process in a timely fashion are keys to maximizing profits from a drug or chemical within the exclusive marketing period allowed by a patent. The timely implementation of reliable processes is the key to continued financial health of pharmaceutical companies. The role of process research and development (R&D) is to ensure that high-quality material is provided on time to fulfill the needs of developing a compound. There is also growing realization that successful process R&D requires different equipment and different approaches from those used in conventional laboratory work for discovery of active compounds. Practical processes must be developed to reap the rewards of basic research, and without down-to-earth applied research there will be no sustained basic research. The reliability of scale-up operations can have a significant impact on cost of the drug substances, and process conditions must be chosen wisely. One of the goals of successful process development is to design and introduce a smooth-running manufacturing process.

[1]  D. Askin,et al.  Synthesis of synvinolin: extremely high conversion alkylation of an ester enolate , 1991 .

[2]  Stephen Stinson DRUG FIRMS RESTOCK ANTIBACTERIAL ARSENAL: Growing bacterial resistance, new disease threats spur improvements to existing drugs and creation of new classes , 1996 .

[3]  Stan Lee,et al.  Process Development: Fine Chemicals from Grams to Kilograms , 1995 .

[4]  Stu Borman REDUCING TIME TO DRUG DISCOVERY , 1999 .

[5]  Stu Borman,et al.  REDUCING TIME TO DRUG DISCOVERY: Recent advances in solid-phase synthesis, informatics, and high-throughput screening suggest combinatorial chemistry is coming of a , 1999 .

[6]  E. M. Kolassa,et al.  Elements of Pharmaceutical Pricing , 1997 .

[7]  L. Dijkhuizen,et al.  A better enzyme for cyclodextrins , 1995 .

[8]  Frank E. Close Cold fusion research , 1992 .

[9]  Anita M. Katti,et al.  Fundamentals of Preparative and Nonlinear Chromatography , 1994 .

[10]  K. Sharpless,et al.  Highly Efficient Epoxidation of Olefins Using Aqueous H2O2 and Catalytic Methyltrioxorhenium/Pyridine: Pyridine-Mediated Ligand Acceleration , 1997 .

[11]  Maureen Rouhi SEPARATIONS WITH CARBON DIOXIDE: Micelles provide havens for hydrophilic species in liquid C0 , 1997 .

[12]  Stu Borman Combinatorial Chemistry: Industry is embracing the technology 'totally,' as researchers continue to advance the art of rapid synthesis and screening , 1998 .

[13]  K. Gadamasetti Process Chemistry in the Pharmaceutical Industry , 1999 .

[14]  Steve S. Y. Wang,et al.  Investigation of a thermal runaway hazard‐drum storage of thionyl chloride/ethyl acetate mixture , 1994 .

[15]  Stu Barman Protein targets of bioactive natural products probed , 1999 .

[16]  K. Weissermel,et al.  Industrial Organic Chemistry , 1978 .

[17]  E. Zass,et al.  A guide for the perplexed organic experimentalist , 1978 .

[18]  Oljan Repič Principles of Process Research and Chemical Development in the Pharmaceutical Industry , 1998 .

[19]  Don W. Green,et al.  Perry's chemical engineers' handbook. 7th ed. , 1997 .

[20]  N. Soundararajan,et al.  Improved synthesis of aryl 1,1-dimethylpropargyl ethers , 1994 .

[21]  A. R. Tatchell,et al.  Vogel's Textbook of Practical Organic Chemistry , 1996 .

[22]  Royston M. Roberts,et al.  Serendipity: Accidental Discoveries in Science , 1989 .